Ameritox

Ameritox in the News

  • June 24, 2016
    UNITE holds Shoot Hoops Not Drugs event

    So many life lessons can be learned from the game of basketball,” former University of Kentucky basketball player Jeff Sheppard said. “It’s the least I can do to spend some time with the kids in our communities and deliver a message about basketball but a message of hope as well about staying away from drugs and making the right decisions.”

    Sheppard along with former UK Wildcat Jarrod Polson joined forces with Operation Unite for the 5th Annual Shoot Hoops Not Drugs event. Over 100 children from across the area came to the event to learn basketball fundamentals and an important message about drug abuse.

    “Just the overall message of the camp is just trying to get kids away from the drug scene and how it’s been prevalent in the mountains. Anything to do to prevent that and help those kids and get them on a different path is something I like to do,” Polson said.

    UNITE joined together with Ameritox, a company that “the nation’s leader in pain medication monitoring, offering laboratory services and practice management tools to help clinicians coordinate and optimize the care of chronic pain patients,” according to its website.

    Ameritox’s director of communications, Lon Wagner, said, “We (Ameritox) wanted to sponsor this event. We’re involved in battling the prescription drug epidemic, and so is Operation Unite. Part of our mission, as we say, is to prevent human tragedy.”

    “We want to instill in the kids a couple of things,” Wagner said. “Don’t do drugs that don’t belong to you. Secondly [this camp] is a good, healthy activity. Even if you never end up playing basketball, you’re out here, exercising, getting your heart rate up and doing something positive.”

    Sheppard and Polson taught children of all ages the fundamentals of basketball, ranging from basic ball handling skills to defensive stances. This was the final Shoot Hoops Not Drugs camp that Operation UNITE held.

    Operation UNITE will also be holding a week long leadership camp at the end of July at the University of Cumberlands.

    About Ameritox
    Ameritox helped pioneer the prescription drug monitoring necessary to address the national epidemic of prescription drug misuse, abuse and diversion. As a trusted leader in medication monitoring, Ameritox provides medical and business professionals with health care solutions that can help improve patient care and prevent tragedy. Ameritox, headquartered in Baltimore, Md., has laboratory facilities in Greensboro, N.C.

    Visit the Ameritox website at: www.ameritox.com
    Follow Ameritox on Twitter: www.twitter.com/ameritox

    Contact: Lon Wagner
    Director of Communications, Ameritox
    (336) 387-7742
    lon.wagner@ameritox.com

    Josh Silberberg
    30 Point Strategies
    (202) 304-1546
    joshua@30point.com



  • June 10, 2016
    Ameritox Partners for Third Year with Operation UNITE Youth Basketball Camps Focused on Drug Abuse Prevention

    “Shoot Hoops, Not Drugs” summer basketball camps offer rural Kentucky students the necessary skills to help prevent drug misuse and abuse

    BALTIMORE, MD. – June 10, 2016 — AmeritoxSM, a national leader in medication monitoring solutions, will sponsor for the third consecutive year a series of basketball camps organized by Kentucky-based Operation UNITE. The camps are headed by former University of Kentucky basketball stars who teach basketball skills that also incorporate anti-drug messages aimed at boosting students’ self-worth.

    “By hosting these basketball camps for more than a decade, Operation UNITE has helped instill Eastern Kentucky youth with the self-esteem needed to steer clear of the prescription drug abuse that has devastated their community,” said Scott Walton, Ameritox CEO. “Ameritox is proud to sponsor these camps, because like Operation UNITE, we know that this epidemic can only be stopped by preventing the next generation from succumbing to opioid misuse and abuse.”

    Operation UNITE was created by Kentucky Congressman Hal Rogers in 2003 to bring together government, law enforcement and businesses in fighting Kentucky’s rampant drug problems. The camps were created to foster strong deterrents for drug abuse in school-aged children.

    Ameritox employees will provide support to Operation UNITE staff at the camps.
     
    “We’re grateful to once again have Ameritox’s generous support, but we’re even more grateful that they continue to fight alongside us in the battle to prevent our kids from traveling down the frightening path of drug abuse,” said Nancy Hale, CEO of Operation UNITE.

    The five free 2016 camps will be led by former University of Kentucky Final Four MVP Jeff Sheppard. All-SEC Academic Team member Jarrod Polson will join Sheppard for the last three camps. The dates and locations of the camps are:

    • Tuesday, June 14 – Warfield Middle School, Warfield, Martin County
    • Thursday, June 16 – Owsley County High School, Booneville
    • Monday, June 20 – Morgan County High School, West Liberty
    • Tuesday, June 21 – Rodney C. Woods Gym, Wayne County Schools Campus, Monticello
    • Thursday, June 23 – Knott County Sportsplex, 450 Kenny Champion Loop, Leburn

    About Ameritox
    Ameritox helped pioneer the prescription drug monitoring necessary to address the national epidemic of prescription drug misuse, abuse and diversion. As a trusted leader in medication monitoring, Ameritox provides medical and business professionals with health care solutions that can help improve patient care and prevent tragedy. Ameritox, headquartered in Baltimore, Md., has laboratory facilities in Greensboro, N.C.

    Visit the Ameritox website at: www.ameritox.com
    Follow Ameritox on Twitter: www.twitter.com/ameritox

    About Operation UNITE
    Operation UNITE, which stands for Unlawful Narcotics Investigations, Treatment & Education, seeks to fight the drug epidemic by expanding drug awareness and education programs to keep people from using drugs; coordinating drug treatment and outreach programs for those who are already addicted; and operating regional undercover law enforcement task forces for interdiction and prosecution of those dealing drugs.

    Visit the UNITE website at: www.operationunite.org



  • February 22, 2016
    Ameritox Research Confirms Significant Spike in Potential Nonadherence to Opioid Medications

    BALTIMORE, Feb. 22, 2016 — AmeritoxSM, a national leader in medication monitoring solutions, presented new research Friday showing a nearly 20-percent increase in the share of patient samples that do not contain the patient’s prescribed opioid medication. Attendees at the American Academy of Pain Medicine (AAPM) Annual Meeting, held in Palm Springs, California, learned that a full 43 percent of patient samples collected over a period of 31 months ending in July 2015 showed potential nonadherence. The 2012 Ameritox National Prescription Drug Report found that 35.9 percent of patient samples showed potential nonadherence.

    Samples where a prescribed opioid is not detected raise serious concerns about patient care or the risk of drug diversion – intentional or accidental.

    Based on samples collected from more than 447,000 patients between January 2013 and July 2015, the Ameritox data showed that potential nonadherence was greatest among those aged 10-19, at a rate of 62 percent. Though potential nonadherence declined in each decade after that, it remained significant even among those aged 60-69 (potential nonadherence, 39 percent) and those aged 70-79 (potential nonadherence, 37 percent).

    “We understand that many patients find it difficult to have conversations with their doctor about their treatment,” said Ameritox Chief Medical Officer Dr. Tom Smith. “Medication monitoring results can help prompt doctor-patient discussions that lead to improved patient care, and also is an important tool in reducing misuse, abuse and diversion of prescription medication.”

    About Ameritox
    Ameritox helped pioneer the prescription drug monitoring necessary to address the national epidemic of prescription drug misuse, abuse and diversion. As a trusted leader in medication monitoring, Ameritox provides medical and business professionals with health care solutions that can help improve patient care and prevent tragedy. Ameritox, headquartered in Baltimore, Md., has laboratory facilities in Greensboro, N.C.

    Visit the Ameritox website at: www.ameritox.com
    Follow Ameritox on Twitter: www.twitter.com/ameritox

    Contact: Lon Wagner
    Director of Communications, Ameritox
    (336) 387-7742
    lon.wagner@ameritox.com

    Josh Silberberg
    30 Point Strategies
    (202) 304-1546
    joshua@30point.com



  • January 18, 2016
    Ameritox Data on ADHD Stimulant Prescriptions Uncovers Significant Rates of Illicit Drug Use and Potential Nonadherence to Drug Regimen

    WASHINGTON – January 18, 2016 – AmeritoxSM, a national leader in medication monitoring solutions, presented new research showing that in one out of three samples of patients prescribed stimulants to treat attention-deficit/hyperactivity (ADHD) disorder the prescribed drug was not detected. Members of Ameritox’s Medical Affairs team prepared the data for attendees at the American Professional Society of ADHD and Related Disorders (APSARD) Annual Meeting, held in Washington, where conference organizers highlighted the Ameritox report for attendees.

    Based on samples collected from more than 4,000 patients between July 1, 2014 and June 30, 2015, the Ameritox data showed indications that potential nonadherence to prescription stimulants in the treatment of ADHD is associated with elevated rates of illicit drug use as well as non-medical use of opioids and benzodiazepines. In samples where the prescribed stimulant was not detected, THC was present more than 20 percent of the time. Nearly four in ten samples where the prescribed stimulant was not detected tested positive for some combination of a nonprescribed opioid, nonprescribed benzodiazepine, THC and/or cocaine.

    In addition, patients being treated for ADHD with prescription stimulants showed high rates of potential nonadherence across all age groups. Patients over the age of 60 showed the lowest rates of potential nonadherence, with 24.4 percent of samples absent the prescribed drug. Patients between ages 20 and 29 had the highest rates of potential nonadherence, as more than 40 percent of all samples collected from patients in that age range tested negative for their prescribed stimulant.

    “Even in the best case scenarios,” said Ameritox Chief Medical Officer Dr. Tom Smith, “the potential for diversion or illicit drug use is alarmingly high. The misuse, abuse and diversion of ADHD medications cannot be casually brushed aside when these results suggest that even when the prescribed ADHD medication is found there is a nearly one in four chance that the sample will also test positive for potentially dangerous substances.”

    About Ameritox

    Ameritox helped pioneer the prescription drug monitoring necessary to address the national epidemic of prescription drug misuse, abuse and diversion. As a trusted leader in medication monitoring, Ameritox provides medical and business professionals with health care solutions that can help improve patient care and prevent tragedy. Ameritox, headquartered in Baltimore, Md., has laboratory facilities in Greensboro, N.C.

    Visit the Ameritox website at: www.ameritox.com
    Follow Ameritox on Twitter: www.twitter.com/ameritox

    Contact: Lon Wagner
    Director of Communications, Ameritox
    (336) 387-7742
    lon.wagner@ameritox.com

    Josh Silberberg
    30 Point Strategies
    202-304-1546
    josh@30point.com



  • December 17, 2015
    Ameritox Wins Award for Compliance Training

    Respected human capital management firm recognizes value of Ameritox compliance program

    BALTIMORE, Dec. 17, 2015 /PRNewswire/ — AmeritoxSM, a national leader in medication monitoring solutions, today announced the “Ameritox STARK Shark Challenge,” a supplement to annual compliance training that focuses on interactions with potential clients, won a bronze medal as part of the 2015 Brandon Hall Group Excellence in Awards for Learning and Development, Talent Management, and Sales and Marketing.

    Logo – http://photos.prnewswire.com/prnh/20151217/296848LOGO

    “Ameritox’s compliance efforts do not amount to a box we simply check. Our focus ensures responsible expansion of our business, reinforces our mission to strengthen improve patient care and prevent human tragedy, and sets a high standard for our industry,” said Scott Walton, CEO of Ameritox.

    Entries for the Brandon Hall Group Excellence Awards were evaluated by a panel of veteran, independent senior industry experts along with Brandon Hall Group senior analysts and executive leadership. The entries were judged based on their ability to fit the need, the design of the program, functionality and innovation.

    The Ameritox STARK Shark Challenge was redesigned in 2014 with the help of GP Strategies, a sales and technical training consulting firm, to transform pages of flat text into an engaging scenario that invites participation, questions, and ultimately, deepens understanding of a critical component of the Ameritox compliance program.

    “The high quality of work and commitment to driving business results among our award winners never fails to amaze me,” said Rachel Cooke, Chief Operating Officer of Brandon Hall Group and head of the awards program. “But the real winners of this award are Ameritox’s customers and clients because of the innovation and customer focus the company demonstrates.”

    About Ameritox

    Ameritox helped pioneer the prescription drug monitoring necessary to address the national epidemic of prescription drug misuse, abuse and diversion. As a trusted leader in medication monitoring, Ameritox provides medical and business professionals with health care solutions that can help improve patient care and prevent tragedy. Ameritox, headquartered in Baltimore, Md., has laboratory facilities in Greensboro, N.C.

    Visit the Ameritox website at: www.ameritox.com
    Follow Ameritox on Twitter: www.twitter.com/ameritox

    Contact: Lon Wagner
    Director of Communications, Ameritox
    (336) 387-7742

    Genevieve Rozansky
    202-509-0794